Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study --Inhibition of Incisional Infections)

NCT01297959 is registered in ClinicalTrials.gov with Excited States, LLC as lead sponsor.

NCT NCT01297959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01297959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study --Inhibition of Incisional Infections)
Lead sponsor
Excited States, LLC
Phase
Phase 3
Overall status
Completed
Start date
January 10, 2013
Completion date
October 14, 2015
Enrollment
503 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

infections